Remember
 
 
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

February 8, 2007

SpeculatingStocks.com Stock Pick: Insmed, Inc. (INSM)

Stock Price: $1.07


Insmed, Inc. is a biopharmaceutical company focused on the development and commercialization of drugs for the treatment of metabolic diseases and endocrine disorders with unmet medical needs.

INSM holds significant drug assets to treat ALS (Lou Gehrig's disease) and short stature in children due to a growth hormone deficiency. The company is also exploring uses for its Iplex drug in treating insulin resistance, myotonic muscular dystrophy and disorders associated with HIV.

We believe the assets that INSM holds are worth more than the company's current market cap of $107.28 million. The company had $35.27 million in cash and cash equivalents as of their latest balance sheet on September 30, 2006.

INSM experienced strong buying volume yesterday and early morning today. INSM is coming into play as biotech stocks continue to get their fair share of attention.

 
     
Untitled Document